BIOMAT Database Logo BIOMAT Database Logo

Fatal graft-versus-host reaction following granulocyte transfusions. 1982

W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006087 Graft vs Host Reaction An immunological attack mounted by a graft against the host because of HISTOINCOMPATIBILITY when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. HLA Sensitization,Human Leukocyte Antigen Sensitization,Sensitization, HLA
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Related Publications

W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Graft-versus-host disease following blood transfusions.
February 1983, Blut,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Acute leukemia and granulocyte transfusion: Fatal graft-versus-host reaction following transfusion of cells obtained from normal donors.
August 1978, The Journal of pediatrics,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Fatal graft-versus-host and probable graft-versus-graft reaction due to an unirradiated granulocyte transfusion after allogeneic marrow transplantation.
June 1983, Transplantation proceedings,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
[Graft-versus-host reaction following granulocyte transfusion from a normal donor (author's transl)].
January 1978, Blut,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion.
February 1981, Blood,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Graft-versus-host disease in lymphoblastic lymphoma following blood transfusions.
October 1983, Middle East journal of anaesthesiology,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Transfusions and graft-versus-host disease.
March 1989, Lancet (London, England),
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Granulocyte factor and graft-versus-host reaction in rats. I. The inhibitory effect of granulocyte factor on the local graft-versus-host reaction in rats.
January 1987, Archivum immunologiae et therapiae experimentalis,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Graft-versus-host reaction following blood product transfusion.
June 1982, The American journal of medicine,
W Schmidmeier, and W Feil, and W Gebhart, and W Grisold, and F Gschnait, and W Hinterberger, and P Höcker, and K Jellinger, and R Krepler, and E Machacek
Graft-versus-host disease from leukocyte transfusions.
September 1983, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!